EchoGo® Heart Failure vs ASSURE Wearable ECG
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is an AI platform designed for rapid diagnosis of HFpEF by analyzing routine echocardiograms, providing clinical decision support. In contrast, Tool B, ASSURE Wearable ECG, is a wearable device focused on continuous heart rate monitoring and data collection for at-risk cardiac patients, emphasizing remote patient management. While both leverage AI in cardiology, their distinct data inputs (echocardiograms vs. wearable ECG) and primary functions (diagnostic aid vs. continuous monitoring) make them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform designed to analyze routine echocardiograms for the detection of Heart Failure with preserved Ejection Fraction (HFpEF), providing insights to support clinical decisions. The ASSURE Wearable ECG is a non-therapeutic device for continuous heart rate monitoring and data collection, primarily for at-risk cardiac patients.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips using AI to detect HFpEF. The ASSURE Wearable ECG utilizes a wearable device with embedded ECG sensors (SensorFit Garment) for continuous heart rate monitoring, employing an ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence to filter motion artifacts.
EchoGou00ae Heart Failure delivers AI-powered HFpEF detection insights within 20 minutes, along with automated structured reports that can be delivered to PACS via DICOM workflow. The ASSURE Wearable ECG provides automatic episode storage, alert-based notifications, and physiologic trend data, all accessible through the Kestra CareStation remote patient data platform for clinician review.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For the ASSURE Wearable ECG, pricing details require direct contact with Kestra Medical Technologies.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF, and was trained on over 10 years of outcome data. The ASSURE Wearable ECG features an ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence for filtering motion artifacts to improve arrhythmia detection accuracy.
EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS. The ASSURE Wearable ECG system includes a wearable device, a mobile application, and a cloud-based remote patient data platform (Kestra CareStation) for clinician review.